Oxford-AstraZeneca Nasal COVID-19 Vaccine Falters in Clinical Trial
Oxford-AstraZeneca Nasal COVID-19 Vaccine Falters in Clinical Trial
Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.
Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.
mucosal vaccine
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward
Jef Akst | Jun 13, 2022 | 10+ min read
Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?
Mucosal Vaccines Protect Mice from Viruses, Cancer
Emma Yasinski | Jun 1, 2021 | 2 min read
Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.
Bacteria Boost Vaccine Effectiveness
Sabrina Richards | Feb 10, 2013 | 5 min read
Researchers are looking to microbes to improve immune responses to a wide range of vaccines.